84 related articles for article (PubMed ID: 17408061)
1. Nifedipine, a calcium-channel blocker, inhibits advanced glycation end-product-induced expression of monocyte chemoattractant protein-1 in human cultured mesangial cells.
Matsui T; Yamagishi S; Nakamura K; Inoue H; Takeuchi M
J Int Med Res; 2007; 35(1):107-12. PubMed ID: 17408061
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation.
Yamagishi S; Inagaki Y; Kikuchi S
Drugs Exp Clin Res; 2003; 29(4):147-52. PubMed ID: 15018305
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M; Makita Z
J Biol Chem; 2002 Jun; 277(23):20309-15. PubMed ID: 11912219
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
Lynn EG; Siow YL; Frohlich J; Cheung GT; O K
Kidney Int; 2001 Aug; 60(2):520-32. PubMed ID: 11473635
[TBL] [Abstract][Full Text] [Related]
9. Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells.
Lynn EG; Siow YL; O K
Kidney Int; 2000 Apr; 57(4):1472-83. PubMed ID: 10760083
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine, a calcium channel blocker, inhibits inflammatory and fibrogenic gene expressions in advanced glycation end product (AGE)-exposed fibroblasts via mineralocorticoid receptor antagonistic activity.
Matsui T; Takeuchi M; Yamagishi S
Biochem Biophys Res Commun; 2010 May; 396(2):566-70. PubMed ID: 20438710
[TBL] [Abstract][Full Text] [Related]
11. [Effect of advanced glycosylation end products on oxidative stress and MCP-1 in human renal mesangial cells].
Feng M; Xu CB; Wen JP; Lin GF; Lv Q; Huang GL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Jul; 30(4):306-10, 313. PubMed ID: 25330663
[TBL] [Abstract][Full Text] [Related]
12. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone.
Gruden G; Setti G; Hayward A; Sugden D; Duggan S; Burt D; Buckingham RE; Gnudi L; Viberti G
J Am Soc Nephrol; 2005 Mar; 16(3):688-96. PubMed ID: 15677312
[TBL] [Abstract][Full Text] [Related]
13. [Curcumin inhibited the proliferation and extracellular matrix production of human mesangial cells].
Bao HY; Chen RH; Huang SM; Pan XQ; Fei L
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):822-6. PubMed ID: 14728887
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine inhibits tumor necrosis factor-alpha-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cells.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2005; 31(1):13-7. PubMed ID: 15921025
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of monocyte chemoattractant protein-1 in human monocytes by exposure to advanced glycosylation end products.
Wang BR; Liu NF
Acta Pharmacol Sin; 2001 Jan; 22(1):67-70. PubMed ID: 11730565
[TBL] [Abstract][Full Text] [Related]
17. C-Type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells.
Osawa H; Yamabe H; Kaizuka M; Tamura N; Tsunoda S; Baba Y; Shirato K; Tateyama F; Okumura K
Nephron; 2000 Dec; 86(4):467-72. PubMed ID: 11124596
[TBL] [Abstract][Full Text] [Related]
18. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation.
Inagaki Y; Yamagishi S; Okamoto T; Takeuchi M; Amano S
Diabetologia; 2003 Feb; 46(2):284-7. PubMed ID: 12627328
[TBL] [Abstract][Full Text] [Related]
20. [Advanced glycation end products stimulate human endothelial cells to produce monocyte chemoattractant protein-1].
Guo ZJ; Hou FF; Liang M; Wang L; Zhang X; Liu ZQ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1075-9. PubMed ID: 12899782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
